120
Participants
Start Date
December 8, 2020
Primary Completion Date
June 7, 2021
Study Completion Date
July 7, 2021
CPPLAI
In this intervention, after general anesthesia patients will receive intraoperative combined periportal and preperitoneal bupivacaine 0.25% 2-3 mg/kg diluted in 40 ml normal saline.
Placebo
In this intervention, after general anesthesia patients will receive intraoperative combined periportal and preperitoneal 40 ml of sterile water.
Bupivacaine 0.25%
In this intervention, after general anesthesia patients will receive intraoperative combined periportal and preperitoneal bupivacaine 0.25% 2-3 mg/kg diluted in 40 ml normal saline.
King Khalid University Hospital, Riyadh
King Khalid University Hospital
OTHER